Enerpac Tool
EPAC
Precision Drilling
PDS
Halozyme Therapeutics
HALO
4
Workday
WDAY
5
Lantheus
LNTH
US Stock MarketDetailed Quotes
GOSS Gossamer Bio
- 1.280
- 0.0000.00%
Close Mar 25 16:00 ET
- 1.250
- -0.030-2.34%
Post 20:01 ET
290.84MMarket Cap-5.12P/E (TTM)
1.310High1.240Low1.11MVolume1.310Open1.280Pre Close1.41MTurnover0.60%Turnover RatioLossP/E (Static)227.22MShares1.55052wk High9.85P/B235.10MFloat Cap0.49952wk Low--Dividend TTM183.67MShs Float27.150Historical High--Div YieldTTM5.47%Amplitude0.453Historical Low1.268Avg Price1Lot Size
About Gossamer Bio Company
Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions. The company was founded by Faheem Hasnain and Sheila Gujrathi on October 26, 2015 and is headquartered in San Diego, CA.
Company Profile
SymbolGOSS
Company NameGossamer Bio
Listing DateFeb 8, 2019
Issue Price16.00
Founded2015
CEOMr. Faheem Hasnain
MarketNASDAQ
Employees145
Fiscal Year Ends12-31
Address3115 Merryfield Row,Suite 120
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-684-1300
Websitehttp://www.gossamerbio.com
Company Executives
- Name
- Position
- Salary
- Faheem Hasnain
- Chairman of the Board, President and Chief Executive Officer
- 2.10M
- Bob Smith
- Chief Commercial Officer
- 1.33M
- Dr. Richard Aranda, M.D.
- Chief Medical Officer
- --
- Bryan Giraudo
- Chief Operating Officer, Chief Financial Officer and Principal Accounting Officer
- 1.29M
- Caryn Peterson
- Executive Vice President, Regulatory Affairs
- --
- Christian Waage
- Executive Vice President, Technical Operations and Administration
- --
- Skye Drynan
- Independent Director
- --
- Dr. Sandra Milligan, J.D.,M.D.
- Independent Director
- 81.82K
- Russell J. Cox
- Independent Director
- 87.32K
- Dr. Thomas O. Daniel, M.D.
- Lead Independent Director
- 98.82K
- Dr. Steven Nathan, M.D.
- Independent Director
- --
- Dr. John D. Quisel, J.D.,PhD
- Independent Director
- 133.61K
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings